´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸ : 2019-11-14±³À°ÀÏÀÚ : 2019-11-14
±³À°Àå¼Ò : ¿©¼öÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ
´ã´çÀÚ : ¹Ú¼Ò¹Î
¿¬¶ôó : 02-398-5055
À̸ÞÀÏ :
office@kscpt.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¸¶ÃëÅëÁõÀÇÇаú, °¡Á¤ÀÇÇаú¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
Àü¶ó³²µµ±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í »çÀü - Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø 7¸¸¿ø , ºñȸ¿ø 20¸¸¿øÇöÀå - Á¤È¸¿ø 20¸¸¿ø, ÁØȸ¿ø 10¸¸¿ø , ºñȸ¿ø 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 13:15~14:00 Streamlining Drug Development Using Modeling and Simulation on Earth and in Space Distinguished Professor Hartmut Derendorf(College of Pharmacy University of Florida)
ÈÞ½Ä 11-14 ÄÁº¥¼ÇȦ 14:00~14:10 coffee & poster ()
±âŸ 11-14 ÄÁº¥¼ÇȦ 14:10~14:15 Àλ縻 (½Ä¾àó Àӻ󿬱¸°úÀå, Àӻ󿬱¸°ú ¹Ì·¡ ¹æÇâ) ÀÌÀ±¼÷ °úÀå(½ÄÇ°ÀǾàÇ° ¾ÈÀüó)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 14:15~14:35 The in silico proarrhythmic risk assessment method proposed by CiPA – Is it worth trying? ÀÓµ¿¼® ±³¼ö(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 14:35~14:55 Whole body Physiologically Based Pharmacokinetic Modeling of Herceptin and Human Pharmacokinetic Prediction ÀÓÇü¼® ±³¼ö(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 14:55~15:15 Sex Differences in Pharmacokinetics and Pharmacodynamics of Zolpidem À±¼ºÇý ±³¼ö(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 15:15~15:35 °øÀ¯Çü repository¸¦ ÅëÇÑ ¸ðµ¨¸µ & ½Ã¹Ä·¹ÀÌ¼Ç È°¼ºÈ À±ÈÖ¿ ±³¼ö(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)
ÈÞ½Ä 11-14 ÄÁº¥¼ÇȦ 15:35~15:50 coffee & poster ()
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 15:50~16:15 ÀÓ»óȯ°æ¿¡¼ÀÇ ÀÓ»ó¾àÇבּ¸ Çù·Â¸ðÇü ±èÀº°æ ±³¼ö(¼¿ï´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 16:15~16:40 ÀÓ»óÇù·Â¸ðµ¨ ¿¬±¸µ¿Ç⠺м® ¹× °¡Ä¡±â¹ÝÀû ÇÔÀÇ ±èÀº¿µ ±³¼ö(Áß¾Ó´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 16:40~17:05 ±³À°°ú ¿¬±¸¿¡¼ÀÇ ÀÓ»ó¾à¸®-ÀÓ»ó¾àÇÐ Çù·Â ¸ðµ¨ ¹Ú¹Î¼ö ±³¼ö(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
ÈÞ½Ä 11-14 ÄÁº¥¼ÇȦ 17:05~17:20 coffee & poster ()
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 17:20~17:45 Codevelopment of anti-cancer drug and companion diagnosis ½Å¿µ±â ±³¼ö(¼¿ï´ëÇб³ ¾àÇдëÇÐ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 17:45~18:10 Preclinical study of SAMiRNA-AREG(siRNA nanoparticle antifibrosis drug) ¹ÚÇÑ¿À ´ëÇ¥(¢ß¹ÙÀÌ¿À´Ï¾Æ)
±³À°½Ã°£ 11-14 ÄÁº¥¼ÇȦ 18:10~18:30 Áٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ ½Å°æ°èÁúȯÀÇ Ä¡·á ÁÖ°æ¹Î ±³¼ö((ÁÖ)¸Þµð³ë)
ÈÞ½Ä 11-14 ÄÁº¥¼ÇȦ 18:30~18:35 Æóȸ»ç ()